Why the study?
Does Qiliqiangxin improve cardiac remodeling and dysfunction in thirteen-week-old spontaneously hypertensive rats?
Population
Thirteen-week-old spontaneously hypertensive rats (SHRs)
Comparison
Qiliqiangxin daily intragastric administration… vs Saline daily intragastric administration for one…
Design
Preclinical
Follow-up
1 year
Authors
Loading...
Hypothesis-generating for QLQX in hypertensive remodeling; leaves open clinical translation pending human trials.
Does Qiliqiangxin improve cardiac remodeling and dysfunction in thirteen-week-old spontaneously hypertensive rats?
Long-term treatment with Qiliqiangxin protects against cardiac remodeling and dysfunction in a hypertensive rat model, potentially via upregulation of PPARs and PGC-1α.
Wang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: